Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. - Wikidata - wikimedia - TriplyDB

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.

http://www.wikidata.org/entity/Q34531322

about

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism Complementary and alternative medicine treatments for children with autism spectrum disorders A review of complementary and alternative treatments for autism spectrum disorders My experience learning about autism Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.Chemicals, Nutrition, and Autism Spectrum Disorder: A Mini-Review Possible Benefit of Dietary Carnosine towards Depressive Disorders Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study Physiology and pathophysiology of carnosine.Complementary and Alternative Therapies for Autism Spectrum Disorder The status of pharmacotherapy for autism spectrum disorders Oxidative pathways as a drug target for the treatment of autism The neuroprotective effects of carnosine in early stage of focal ischemia rodent model.On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.Treatments for biomedical abnormalities associated with autism spectrum disorder.Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia.A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.Carnosine treatment for gulf war illness: a randomized controlled trial Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts.Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans.Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.Possible ameliorative effects of antioxidants on propionic acid / clindamycin - induced neurotoxicity in Syrian hamsters.Biological functions of histidine-dipeptides and metabolic syndrome.Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.Inhibition of tumour cell growth by carnosine: some possible mechanisms.Metabolic pathology of autism in relation to redox metabolism.Antioxidation status and histidine dipeptides content in broiler blood and muscles depending on protein sources in feed.Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies.Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease.Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms.Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial.Therapeutic efficacy of natural dipeptide carnosine against human cervical carcinoma cells.Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.Depression, Diabetes and Dementia: Formaldehyde May Be a Common Causal Agent; Could Carnosine, a Pluripotent Peptide, Be Protective?The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo-controlled trial.The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder.

P2860

Q22241227-FB1E8702-4B07-455F-89A4-22E85A82185F Q22252305-EB2AD14F-81E3-40B7-BFAA-6144816159E8 Q24603000-E66E9384-B487-4CA2-80EA-E60AA7352FFC Q24630108-8B0073CA-5E91-49EE-908A-D7E95B711C26 Q24630557-7EEDAB5C-071A-4DCA-9816-18EFEBADC1CC Q26744037-D64EFB9D-0B3E-4FA4-B8AF-756F6720A384 Q26752731-B661AD64-99C8-4D12-B18F-E6F2C5844A71 Q26783380-731106B2-1054-4F39-8517-AD7A849CFA71 Q27014201-0963F28F-88EA-4E04-939E-30FAFC7B2FFC Q27496706-00367CEC-9A10-4D17-825A-A4B02748EC8E Q27692648-2C619C92-EC1E-4F79-BDA3-465729B553B7 Q28082433-DAF64B07-8DE6-403F-A2FE-AF4639958548 Q28239931-31535C72-93BB-4CFB-88E8-9F2EFAEA7F5F Q28295948-01D16C29-F1D4-4BA8-B627-0CEFEF99157A Q33626923-7DF18A97-99FE-4D72-88D9-BB6F225F3F87 Q33714263-3F533FEE-0433-43F1-940F-0A7B4B35CB92 Q33814205-A729C4BE-70A7-466D-802C-CB92A03B4880 Q34066260-5EFA621F-CCCB-47C7-B565-85A589EAC0A1 Q34392818-7CEAFBD3-CE51-4C6A-803C-C53042C95EDF Q34403718-7366BA4A-4F15-460D-B5E5-FD0886257013 Q35179602-606D247F-2925-48F3-BDA2-427110C648E3 Q35565861-6D0F6CF3-670C-470C-B883-F6CB0C93AFD6 Q35800330-6EC279A0-6E90-48DB-B64B-AB1C153748E1 Q36435992-FAE13C7D-6461-4F7B-AF60-4D47D3FE6767 Q37309388-C61B3FA1-9645-47BD-B57F-0849D6FC9A89 Q37620472-34A9D5DD-3116-4589-839B-A11B9DCE5FEC Q37774098-D96C17CF-E40C-4B0C-AA25-6F4671E3A754 Q37774100-E50CC60C-689F-424D-9B79-E2CCDBEDA3C9 Q38167611-DFBEEE29-E208-4577-9AA7-57E8D21E7A5D Q38202986-AB25D62F-620E-409D-A430-390338AD7F2E Q38424615-BB699EEB-A1EA-4B60-AE88-548E61783FD3 Q38601092-F8182205-7440-484B-BF65-F73D51CA8F10 Q38777574-AE968701-B0FD-4DFE-A183-B03F2E5A2340 Q39384617-E0D7EA3D-53D5-4555-AD48-BD9D8D5E75BF Q39867835-71F55760-0A80-4B9E-84FA-3300036D47D2 Q39900326-ACFCA73D-C3A7-47DE-BBC4-5C863B8E3455 Q40060825-0F95D99F-BCA8-44B2-9472-27FE7B486871 Q41790229-E1299347-C659-4722-B873-DF1F30B91DC6 Q46330764-34AA63FA-4A0B-46C9-BCA8-C075B0C864FE Q47551499-CDD83364-BE74-4F5E-B8F6-3A627F6489B0

P2860

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.

http://www.wikidata.org/entity/Q34531322

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@ast

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@en

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@nl

type

label

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@ast

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@en

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@nl

prefLabel

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@ast

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@en

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@nl

P1433

Q34531322-3C879D9A-8CD2-4203-938C-4949BC28EC34

P1476

Q34531322-0975F93B-0900-4225-8782-7F5A6D9B7D01

P2093

Q34531322-434A99FF-FD60-4173-B3F1-3D310A477D4B

Q34531322-4F9C292A-D81C-4EE1-A27D-E37363420F46

Q34531322-5139854E-156A-489F-95B6-4C69A573FEA2

Q34531322-6C3C31EA-20BB-437C-894E-53322E40379A

Q34531322-7539704D-406E-4D07-A346-FCD6A6D1DEE8

Q34531322-88E2616E-9E46-4166-94C0-E41D13171FBF

Q34531322-E8C75EA6-FE33-415C-AE73-1573FFEC9293

P2860

Q34531322-26BB47B9-E82D-4BB4-A8D6-91360346DA09

Q34531322-32A19260-8162-4FF7-8AE0-A101C3EE2B4D

Q34531322-3A442181-C492-4DA7-BE3D-B1E880736A66

Q34531322-8829613F-B597-4B20-80AC-C9040782FE77

Q34531322-9F1B87E0-37FB-45D8-B213-BDDB59912889

Q34531322-A1238F3B-8FAB-49EF-81DE-36151F5FCEA8

Q34531322-AA3320D9-2E47-48C9-A90C-8B1AA2A6D4FD

Q34531322-BF1DEE56-75BA-462E-9C9E-E867111FED15

Q34531322-BFCE669B-920B-4858-8D3C-F4EFC468D371

Q34531322-D5DB8315-7253-4899-A59F-297721750541

P304

Q34531322-8F78AC50-5274-48EC-9754-6C3936067297

P31

Q34531322-F32A6650-620F-4B46-899C-98EB5E5D4E46

P356

Q34531322-08355136-205D-49DD-8770-A34B2313B662

P433

Q34531322-9F6CB127-3017-4528-BC16-958A69687715

P478

Q34531322-15F4B3FC-4A31-47A2-B781-E2C0BFA4B7C9

P577

Q34531322-954ED4B9-E5AD-4F5B-9C34-02897C34BC73

P5875

Q34531322-C399E504-C84D-473C-BD53-526310D015F7

P698

Q34531322-1C68D077-11D9-462C-8104-6095898D2B0A

P921

Q34531322-71157F8C-41A5-4A85-A937-4B79BAB0CAC0

Q34531322-AB675BA9-537B-4C4B-836A-E061D6423992

Q34531322-F508DADE-4C4E-4553-A7D3-C39DF12377FC

P356

08830738020170111501

P1433

Journal of Child Neurology

P1476

Double-blind, placebo-controll ...... h autistic spectrum disorders.

@en

P2093

Carter Black

http://www.w3.org/2001/XMLSchema#string

Cathleen P Buchanan

http://www.w3.org/2001/XMLSchema#string

Jamie Komen

http://www.w3.org/2001/XMLSchema#string

Karla Schaefer

http://www.w3.org/2001/XMLSchema#string

Marina Becker

http://www.w3.org/2001/XMLSchema#string

Mary C Aimonovitch

http://www.w3.org/2001/XMLSchema#string

Michael G Chez

http://www.w3.org/2001/XMLSchema#string

P2860

Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei

Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures.

A possible new role for the anti-ageing peptide carnosine.

Medial temporal lobe structures and autism: a review of clinical and experimental findings.

Glutamate, GABA and epilepsy.

Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders.

Autism: electroencephalogram abnormalities and clinical improvement with valproic acid.

Carnosine modulates zinc and copper effects on amino acid receptors and synaptic transmission.

Histoanatomic observations of the brain in early infantile autism.

Carnosine protects rats under global ischemia.

P304

833-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/08830738020170111501

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10900797

http://www.w3.org/2001/XMLSchema#string

P698

12585724

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum